Table 2.

Distribution of CKD-MBD composite scores, overall and by region

	Above target				Outside targeta
CKD-MBD composite score	Overall	USA	Canada	Europe	Overall	USA	Canada	Europe
No. of patients	12 235	7577	580	4078	19 313	10 699	1046	7568
MBD 0	55	54	50	56	35	39	28	30
MBD 1	34	33	35	35	41	40	43	44
PTH	24	23	37	23	39	33	49	45
Ca	4	3	2	6	14	15	16	13
P	72	74	61	71	47	52	35	41
MBD 2	11	12	14	10	21	19	24	23
PTH, P	88	90	89	83	61	60	56	62
PTH, Ca	4	3	9	5	14	11	21	15
P, Ca	8	7	3	12	25	28	24	22
MBD 3	1	1	1	1	4	3	5	4

Values indicate % of patients (for MBD rows) or % of patients in group (MBD 1 and MBD 2 subdistributions). Subdistributions for MBD 1 and MBD 2 indicate which CKD-MBD markers are above or outside target. Europe includes Belgium, France, Germany, Italy, Spain, Sweden and the UK. CKD-MBD marker targets used: PTH, 150–600 pg/mL; Ca, 8.4–10.2 mg/dL; P, 3.5–5.5 mg/dL.

^aSensitivity analysis.